| 1 | Study | 1.79% | |
| 2 | Patients | 1.79% | |
| 3 | Report | 1.79% | |
| 4 | Case | 1.79% | |
| 5 | Patient | 1.43% | |
| 6 | Risk | 1.07% | |
| 7 | Disease | 1.07% | |
| 8 | Vaccine | 0.71% | |
| 9 | Hospital | 0.71% | |
| 10 | Cancer | 0.71% | |
| 11 | Therapy | 0.71% | |
| 12 | Could | 0.71% | |
| 13 | Breast | 0.71% | |
| 14 | Damage | 0.71% | |
| 15 | Peritoneal | 0.71% | |
| 16 | Alzheimer’s | 0.71% | |
| 17 | Health | 0.71% | |
| 18 | Rare | 0.71% | |
| 19 | Weight | 0.71% | |
| 20 | Potential | 0.71% | |
| 21 | Trial | 0.71% | |
| 22 | Encephalitis | 0.71% | |
| 23 | Chronic | 0.71% | |
| 24 | Tertiary | 0.71% | |
| 25 | Cardiovascular | 0.71% | |
| 26 | Phase | 0.71% | |
| 27 | Teen | 0.36% | |
| 28 | Some | 0.36% | |
| 29 | Yeast | 0.36% | |
| 30 | Spectrum | 0.36% | |
| 31 | Angel | 0.36% | |
| 32 | Candidemia | 0.36% | |
| 33 | Gain | 0.36% | |
| 34 | Loss | 0.36% | |
| 35 | scRNA-Seq | 0.36% | |
| 36 | Sustainable | 0.36% | |
| 37 | Longer | 0.36% | |
| 38 | Cutaneous | 0.36% | |
| 39 | Decade | 0.36% | |
| 40 | Composition | 0.36% | |
| 41 | Myositis | 0.36% | |
| 42 | Day | 0.36% | |
| 43 | Two | 0.36% | |
| 44 | Lifespan | 0.36% | |
| 45 | Japan | 0.36% | |
| 46 | Syndrome | 0.36% | |
| 47 | Drug | 0.36% | |
| 48 | Vasospasm | 0.36% | |
| 49 | Drugs | 0.36% | |
| 50 | Global | 0.36% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||
Systemic Sclerosis Organ Damage Revealed Through scRNA-Seq
Genetic Engineering and Biotechnology News
2025-06-18 07:35:17